A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors
Purpose: To evaluate the clinical outcomes and treatment related toxicities of charged particle-based re-irradiation (reRT; protons and carbon ions) for the definitive management of recurrent or second primary skull base and head and neck tumors. Materials and Methods: The Preferred Reporting Items...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Particle Therapy Co-operative Group
2021-06-01
|
Series: | International Journal of Particle Therapy |
Subjects: | |
Online Access: | https://theijpt.org/doi/pdf/10.14338/IJPT-20-00064.1 |
id |
doaj-1ffa88101b664c43ad340ced7d242917 |
---|---|
record_format |
Article |
spelling |
doaj-1ffa88101b664c43ad340ced7d2429172021-07-07T17:55:42ZengParticle Therapy Co-operative GroupInternational Journal of Particle Therapy2331-51802021-06-018113115410.14338/IJPT-20-00064.1i2331-5180-8-1-131A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck TumorsMauricio E. Gamez, M.D.0Samir H. Patel, M.D.1Lisa A. McGee, M.D.2Terence T. Sio, M.D.3Mark McDonald, M.D.4Jack Phan, M.D.5Ma M.D. Daniel J.6Robert L. Foote, M.D.7Jean-Claude M. Rwigema, M.D.81 Radiation Oncology, The Ohio State University – The James Cancer Center, Columbus, OH, USA2 Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA2 Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA2 Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA3 Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA4 Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA5 Radiation Oncology, Mayo Clinic, Rochester, MN, USA5 Radiation Oncology, Mayo Clinic, Rochester, MN, USA2 Radiation Oncology, Mayo Clinic, Phoenix, AZ, USAPurpose: To evaluate the clinical outcomes and treatment related toxicities of charged particle-based re-irradiation (reRT; protons and carbon ions) for the definitive management of recurrent or second primary skull base and head and neck tumors. Materials and Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were applied for the conduct of this systematic review. Published work in English language evaluating the role of definitive charged particle therapies in the clinical setting of reRT for recurrent or second primary skull base and head and neck tumors were eligible for this analysis. Results: A total of 26 original studies (15 protons, 10 carbon ions, and 1 helium/neon studies) involving a total of 1,118 patients (437 with protons, 670 with carbon ions, and 11 with helium/neon) treated with curative-intent charged particle reRT were included in this systematic review. All studies were retrospective in nature, and the majority of them (n=23, 88 %) were reported as single institution experiences (87% for protons, and 90% for carbon ion-based studies). The median proton therapy reRT dose was 64.5 Gy (RBE 1.1) (range, 50.0 – 75.6 Gy ), while the median carbon ion reRT dose was 53.8 Gy (RBE 2.5 – 3.0) (range, 44.8 – 60 Gy ). Induction and/or concurrent chemotherapy was administered to 232 (53%) of the patients that received a course of proton reRT, and 122 (18%) for carbon ion reRT patients. ReRT with protons achieved 2-year local control rates ranging from 50% to 86%, and 41% to 92% for carbon ion reRT. The 2-year overall survival rates for proton and carbon ion reRT ranged from 33% to 80%, and 50% to 86% respectively. Late ≥ G3 toxicities ranged from 0% to 37%, with brain necrosis, ototoxicity, visual deficits, and bleeding as the most common complications. Grade 5 toxicities for all treated patients occurred in 1.4% (n = 16/1118) with fatal bleeding as the leading cause. Conclusions: Based on current data, curative intent skull base and head and neck reRT with charged particle radiotherapy is feasible and safe in well-selected cases, associated with comparable or potentially improved local control and toxicity rates compared to historical reRT studies using photon radiotherapy. Prospective multi-institutional studies reporting oncologic outcomes, toxicity, and dosimetric treatment planning data are warranted to further validate these findings and to improve the understanding of the clinical benefits of charged particle radiotherapy in the reRT setting.https://theijpt.org/doi/pdf/10.14338/IJPT-20-00064.1proton therapycarbon ion therapyparticle beam therapycharged particle therapyre-irradiationskull base and head and neck cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mauricio E. Gamez, M.D. Samir H. Patel, M.D. Lisa A. McGee, M.D. Terence T. Sio, M.D. Mark McDonald, M.D. Jack Phan, M.D. Ma M.D. Daniel J. Robert L. Foote, M.D. Jean-Claude M. Rwigema, M.D. |
spellingShingle |
Mauricio E. Gamez, M.D. Samir H. Patel, M.D. Lisa A. McGee, M.D. Terence T. Sio, M.D. Mark McDonald, M.D. Jack Phan, M.D. Ma M.D. Daniel J. Robert L. Foote, M.D. Jean-Claude M. Rwigema, M.D. A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors International Journal of Particle Therapy proton therapy carbon ion therapy particle beam therapy charged particle therapy re-irradiation skull base and head and neck cancer |
author_facet |
Mauricio E. Gamez, M.D. Samir H. Patel, M.D. Lisa A. McGee, M.D. Terence T. Sio, M.D. Mark McDonald, M.D. Jack Phan, M.D. Ma M.D. Daniel J. Robert L. Foote, M.D. Jean-Claude M. Rwigema, M.D. |
author_sort |
Mauricio E. Gamez, M.D. |
title |
A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors |
title_short |
A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors |
title_full |
A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors |
title_fullStr |
A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors |
title_full_unstemmed |
A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors |
title_sort |
systematic review on re-irradiation with charged particle beam therapy in the management of locally recurrent skull base and head and neck tumors |
publisher |
Particle Therapy Co-operative Group |
series |
International Journal of Particle Therapy |
issn |
2331-5180 |
publishDate |
2021-06-01 |
description |
Purpose: To evaluate the clinical outcomes and treatment related toxicities of charged particle-based re-irradiation (reRT; protons and carbon ions) for the definitive management of recurrent or second primary skull base and head and neck tumors.
Materials and Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were applied for the conduct of this systematic review. Published work in English language evaluating the role of definitive charged particle therapies in the clinical setting of reRT for recurrent or second primary skull base and head and neck tumors were eligible for this analysis.
Results: A total of 26 original studies (15 protons, 10 carbon ions, and 1 helium/neon studies) involving a total of 1,118 patients (437 with protons, 670 with carbon ions, and 11 with helium/neon) treated with curative-intent charged particle reRT were included in this systematic review. All studies were retrospective in nature, and the majority of them (n=23, 88 %) were reported as single institution experiences (87% for protons, and 90% for carbon ion-based studies). The median proton therapy reRT dose was 64.5 Gy (RBE 1.1) (range, 50.0 – 75.6 Gy ), while the median carbon ion reRT dose was 53.8 Gy (RBE 2.5 – 3.0) (range, 44.8 – 60 Gy ). Induction and/or concurrent chemotherapy was administered to 232 (53%) of the patients that received a course of proton reRT, and 122 (18%) for carbon ion reRT patients. ReRT with protons achieved 2-year local control rates ranging from 50% to 86%, and 41% to 92% for carbon ion reRT. The 2-year overall survival rates for proton and carbon ion reRT ranged from 33% to 80%, and 50% to 86% respectively. Late ≥ G3 toxicities ranged from 0% to 37%, with brain necrosis, ototoxicity, visual deficits, and bleeding as the most common complications. Grade 5 toxicities for all treated patients occurred in 1.4% (n = 16/1118) with fatal bleeding as the leading cause.
Conclusions: Based on current data, curative intent skull base and head and neck reRT with charged particle radiotherapy is feasible and safe in well-selected cases, associated with comparable or potentially improved local control and toxicity rates compared to historical reRT studies using photon radiotherapy. Prospective multi-institutional studies reporting oncologic outcomes, toxicity, and dosimetric treatment planning data are warranted to further validate these findings and to improve the understanding of the clinical benefits of charged particle radiotherapy in the reRT setting. |
topic |
proton therapy carbon ion therapy particle beam therapy charged particle therapy re-irradiation skull base and head and neck cancer |
url |
https://theijpt.org/doi/pdf/10.14338/IJPT-20-00064.1 |
work_keys_str_mv |
AT mauricioegamezmd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT samirhpatelmd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT lisaamcgeemd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT terencetsiomd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT markmcdonaldmd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT jackphanmd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT mamddanielj asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT robertlfootemd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT jeanclaudemrwigemamd asystematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT mauricioegamezmd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT samirhpatelmd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT lisaamcgeemd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT terencetsiomd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT markmcdonaldmd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT jackphanmd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT mamddanielj systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT robertlfootemd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors AT jeanclaudemrwigemamd systematicreviewonreirradiationwithchargedparticlebeamtherapyinthemanagementoflocallyrecurrentskullbaseandheadandnecktumors |
_version_ |
1721314896289726464 |